Document:

Exhibit 10.1

 

AMENDMENT NO. 1 TO VOTING AGREEMENT

 

This Amendment No. 1 to
Voting Agreement (the “Amendment”) is made and entered into as of January 16, 2018 by and between MoviePass
Inc., a Delaware corporation (the “Company”), and Helios and Matheson Analytics Inc., a Delaware corporation
(“Helios”).

 

WHEREAS, the Company,
Helios and certain stockholders of the Company (the “Key Holders”) entered into that certain Voting Agreement
dated as of December 11, 2017 (the “Voting Agreement”), pursuant to that certain Securities Purchase Agreement,
dated August 15, 2017, as amended on October 6, 2017 and December 11, 2017, between the Company and Helios; and

 

WHEREAS, pursuant
to the Voting Agreement, two directors of the Company shall be designated by the Chief Executive Officer of Helios and three directors
of the Company shall be designated by the Chief Executive Officer of the Company, out of a total of five director seats on the
board of directors of the Company;

 

WHEREAS, as of the
date of this Amendment, the Chief Executive Officers of Helios and the Company have each designated two directors of the Company
and there has remained one vacancy on the board of directors of the Company since December 11, 2017;

 

WHEREAS, the Company
and Helios now desire to amend the Voting Agreement as provided for herein.

 

NOW, THEREFORE,
in consideration of the premises set forth above, which are incorporated in this Amendment as if fully set forth below the parties
hereby agree to amend the Voting Agreement as follows:

 

1.                 
Unless otherwise expressly defined herein, all capitalized terms used in this Amendment shall have the same meaning as they
are defined in the Voting Agreement.

 

2.                 
Section 1.2(a) of the Voting Agreement is hereby amended and restated in its entirety as follows:

 

“Two (2) persons shall be designated
by the Chief Executive Officer of the Company (the “Company Designees”), which individuals shall initially be
Mitch Lowe and Chris Kelly. The parties agree that at least one of the Company Designees shall qualify as an “Independent
Director,” within the meaning of the director independence rules of the NASDAQ Stock Market LLC (“NASDAQ”)
or the New York Stock Exchange (“NYSE”), as applicable, by the then current Board, acting in good faith. If,
at any time during the term of this Agreement, the Board determines that neither of the Company Designees is an Independent Director,
then the Chief Executive Officer of the Company shall promptly cause at least one of the Company Designees who is not an Independent
Director to be removed and replaced in accordance with Subsection 1.4 to comply with this Subsection 1.2(a).”

 

3.                 
Section 1.2(b) of the Voting Agreement is hereby amended and restated in its entirety as follows:

 

“Three (3) persons shall be designated
by the Chief Executive Officer of Helios (the “Helios Designees” and together with the Company Designees, the
“Designees”), two (2) of which individuals shall initially be Theodore Farnsworth and Carl Schramm and the third
of which will be designated by the Chief Executive Officer of Helios by January 31, 2018. The parties agree that at least two (2)
of the Helios Designees shall qualify as Independent Directors, as determined by the then current Board, acting in good faith.
If, at any time during the term of this Agreement, the Board determines that at least two (2) of the Helios Designees are not Independent
Directors, then the Chief Executive Officer of Helios shall promptly cause one or more of the Helios Designees to be removed and
replaced in accordance with Subsection 1.4 to comply with this Subsection 1.2(b).”

 

     

     

    

 

4.                 
This Amendment shall be deemed effective for all purposes retroactively to December 11, 2017, which is the date Helios,
the Company and certain stockholders of the Company entered into the Voting Agreement.

5.                 
Except as specifically amended hereby, the Voting Agreement shall remain in full force and effect and all other terms of
the Voting Agreement remain unchanged. To the extent any provision of the Voting Agreement is inconsistent with this Amendment,
this Amendment shall control.

 

6.                 
This Amendment is intended for the benefit of the parties hereto and their respective permitted successors and assigns,
and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

 

7.                 
The language used in this Amendment will be deemed to be the language chosen by the parties to express their mutual intent,
and no rules of strict construction will be applied against any party.

 

8.                 
This Amendment may be executed in two or more identical counterparts, all of which shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to the other party; provided
that a facsimile signature delivered by fax or e-mail/.pdf transmission shall be considered due execution and shall be binding
upon the signatory thereto with the same force and effect as if the signature were an original, not a facsimile signature, and
delivery by such means shall be due delivery hereof.

 

9.                 
The headings of this Amendment, if any, are for convenience of reference and shall not form part of, or affect the interpretation
of, this letter agreement.

 

[Signature Page Follows]

 

     

     

    

 

 

IN WITNESS WHEREOF, the
parties have executed this Amendment as of the date first written above.

 

	 	MOVIEPASS, INC
	 	 
	 	By: 	/s/ Mitch Lowe
	 	 	Name: Mitch Lowe
Title: Chief Executive Officer

 

	 	HELIOS AND MATHESON ANALYTICS INC.
	 	 
	 	By: 	/s/ Theodore Farnsworth
	 	 	Name: Theodore Farnsworth
Title: Chief Executive Officer

 

 

 

 

[Signature Page to Amendment No. 1 to Voting Agreement]Exhibit 10.2

Employment
Agreement

This EMPLOYMENT
AGREEMENT (the “Agreement”), is entered into as of January 18, 2018, by and between Helios And Matheson Analytics
Inc., a Delaware corporation (the “Company”), and Stuart Benson (“Executive”).

WHEREAS, the Company
recognizes that the Executive has had and is expected to continue to have a critical and essential role in guiding the Company
and in developing the Company’s business;

WHEREAS, the Executive
is expected to make major contributions to the stability, growth and financial strength of the Company;

WHEREAS, the Company
has determined that appropriate arrangements should be taken to encourage the continued attention and dedication of the Executive
to his assigned duties without distraction;

WHEREAS, in consideration
of the Executive’s employment with the Company, the Company desires to provide the Executive with certain compensation and
benefits as set forth in this Agreement;

WHEREAS, as of the
date of this Agreement, the Company wishes to continue Executive’s service as Chief Financial Officer under the terms of
an employment agreement on the terms set forth herein, which shall supersede all previous agreements regarding Executive’s
employment by the Company; and

WHEREAS, the Executive
desires to be employed by the Company on the terms contained in this Agreement.

NOW, THEREFORE,
in consideration of the mutual covenants and agreements herein contained and other good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged, the parties agree as follows:

1.                 
Position and Duties. 

(a)              
The Executive shall serve as the Chief Financial Officer (“CFO”) reporting to
the Company’s Chief Executive Officer (“CEO”) appointed by the Company’s Board of Directors. The Executive
shall primarily work out of 350 Fifth Avenue New York, NY 10118 (the “Executive’s Office”).

(b)              
The Executive shall have such duties, authority and responsibilities as are consistent with
the role of Chief Financial Officer and as may be set forth in the Bylaws of the Company. For purposes of the applicability of
the Company compensation plans to the Executive, Executive shall be considered an “employee.” Executive shall devote
a substantial amount of his business time to the performance of his duties hereunder, but such requirement shall not prevent the
Executive from (i) serving as a member of the board of directors of unaffiliated companies, (ii) serving on civic, charitable,
educational, religious, public interest or public service boards, (iii) managing the Executive’s personal and family investments,
and (iv) engaging in or having an ownership interest in other businesses. In addition, the Executive has disclosed, in writing,
to the Company his involvement in entities and investments other than the Company (collectively, the “Outside Activities”).
The Company shall permit the Executive to continue to engage in the Outside Activities provided that the Executive agrees to disclose
to the Board, in writing, any actual or potential conflict of interest arising out of any such Outside Activity and no such Outside
Activity materially interferes with Executive’s ability to perform his responsibilities hereunder.

    	 		 

     

    

2.                 
Term. This Agreement and Executive’s employment hereunder shall be for an initial
term on the date hereof (the “Effective Date”) and ending on December 31, 2020 (the “Expiration Date”),
unless terminated earlier by the Company or the Executive pursuant to Section 4 of this Agreement (the “Term”).
Thereafter, this Agreement shall automatically be renewed and the Term shall be extended for additional consecutive terms of one
(1) year (each a “Renewal Term”), unless such renewal is objected to by either the Company or the Executive upon ninety
(90) days written notice prior to the commencement of the next Renewal Term. In the event of renewal, the last day of each Renewal
Term shall be deemed the new Expiration Date.

3.                 
Compensation and Related Matters.

(a)              
Base Salary. The Executive’s initial annual base salary for 2017 was $200,000,
less applicable withholdings (the “Base Salary”). The Base Salary shall be payable in accordance with the Company’s
normal payroll procedures in effect from time to time. Commencing on January 1, 2018 the Base Salary was increased to $275,000,
less applicable withholdings. On January 1 of each year, if this Agreement is then in effect, and on each such date thereafter
during the Term, the Base Salary will increase by no less than 7% (the “Minimum Increase”). In the event the
Company becomes subject to the regulations of the Investment Company Act, the Executive’s Base Salary shall increase by 20%
above the amounts specified above. The Compensation Committee and the Board shall review the Base Salary annually and may increase
the Base Salary more than the Minimum Increase, and the term “Base Salary” shall refer to such increased amount. 

(b)              
Annual Bonus. For 2017, the Executive shall receive a performance bonus consisting
of (i) cash in the amount of $150,000, payable no later than January 31, 2018, (ii) 300,000 shares of Company common stock for
extraordinary services related to the Company’s acquisition of a majority stake in MoviePass Inc., and (iii) 100,000 shares
of Company common stock for Executive’s outstanding performance of his general duties in 2017, provided that the shares specified
in the preceding (ii) and (iii) shall vest in their entirety on February 15, 2019 and shall be issued no later than March 15, 2018.
After 2017 and during the Term, the Executive may receive an annual cash bonus and an annual award of shares of common stock, subject
to vesting conditions, in respect of each full or partial fiscal year of the Company, as well as other cash or equity bonuses,
as determined in the sole discretion of the Board based on its assessment of Company and individual performance in relation to
performance targets, a subjective evaluation of Executive’s performance or such other criteria as may be established by the
Board (the “Annual Bonus”). The Annual Bonus, if any, will be paid no later than the 75th day following
the end of the fiscal year to which the Annual Bonus relates. The annual cash target bonus is 50% of the Base Salary and the annual
target award of shares of Company common stock will be, (1) with respect to the first year of the Term, 300,000 shares; (2) with
respect to the second year of the Term, 325,000 shares; and (3) with respect to the third year of the Term, 400,000 shares. The
shares of common stock included in the Annual Bonus, if any, shall vest ratably at the end of each of the six calendar quarters
subsequent to the calendar quarter in which the grant is made. Any award of common stock pursuant to this Agreement shall be subject
to the Company’s receipt of all corporate approvals required by applicable law or the rules and regulations of the Nasdaq
Capital Market or such other national securities exchange in the United States on which the Company’s common stock is then
listed (the “Principal Market”) and the terms of a Restricted Stock Award Agreement to be agreed upon following
the execution of this Agreement and prior the issuance of any common stock award to the Executive (each, an “Award Agreement”).

(c)              
Long Term Incentive Plan. The Executive shall be entitled to participate in all bonus
or other compensation programs adopted by the Company and applicable generally to senior executives of the Company.

    	 	2	 

     

    

(d)              
Equity Incentive Plan. The Executive shall be awarded shares of common stock of the
Company, subject to vesting conditions, as set forth in Exhibit A hereto, subject to the terms of the applicable Award Agreement.
Additionally, the Executive shall be entitled to participate in any and all plans providing for awards of equity or instruments
convertible into equity adopted by the Company and applicable generally to other senior executives of the Company.

(e)              
Business Expenses. The Company shall promptly reimburse the Executive for all reasonable
and necessary business related expenses incurred in connection with the performance of the Executive’s duties hereunder,
in accordance with the policies and procedures then in effect and established by the Company for its senior executive officers,
provided that the Executive furnishes the Company with all supporting information and documentation relevant to such expenses as
the Company may reasonably request. The Executive is entitled, though not required, to travel first class or business class on
all domestic and international flights. 

(f)               
Health Insurance. Executive shall be entitled to participate in any Company health
insurance plan on the same terms and conditions as other Company senior executives are permitted to participate. 

(g)              
Life Insurance. To the extent practicable, the Company shall, during the Term, pay
the premiums of a life insurance policy, providing coverage in the amount of $3,000,000, payable to a beneficiary chosen by Executive,
which insures the life of Executive. Executive shall provide all information and cooperation reasonably necessary to obtain such
life insurance policy. 

(h)              
Automobile Allowance. During the Term, Executive shall receive a monthly automobile
allowance in the amount of Seven Hundred and Fifty Dollars ($750.00) per month for automobile-related expenses.

(i)                
Other Benefits. The Executive shall be entitled to participate in all pension, savings
and retirement plans, welfare and insurance plans, practices, policies, programs and perquisites of employment applicable generally
to other senior executives of the Company. 

(j)                
Vacation. The Executive shall be entitled to accrue up to 20 paid vacation days in
each year, which shall be accrued ratably. The Executive shall also be entitled to all paid holidays given by the Company to its
executives and employees. Any unused vacation days shall be rolled forward to be used in future years, provided that vacation days
shall not accrue further if Executive has 30 accrued but unused vacation days. 

(k)              
Sick Days. The Executive shall be entitled to accrue up to 5 paid sick days in each
year, which shall be accrued ratably. Any unused sick days shall be rolled forward to be used in future years, provided that sick
days shall not accrue further if Executive has 10 accrued but unused sick days.

(l)                
Withholding. All amounts payable to the Executive under this Section 3 shall be subject
to all required federal, state and local withholding, payroll and insurance taxes and requirements.

4.                 
Termination. 

(a)              
Death. The Executive’s employment hereunder shall terminate upon his death.

    	 	3	 

     

    

(b)              
Disability. The Company may terminate the Executive’s employment if the Executive
becomes subject to a Disability. For purposes of this Agreement, “Disability” means the Executive is unable
to perform the essential functions of his position as CFO, with or without a reasonable accommodation, for a period of one-hundred
twenty (120) consecutive days or one-hundred eighty (180) days during any rolling consecutive twelve (12) month period.

(c)              
Termination by Company for Cause. The Company may terminate the Executive’s employment
for Cause. For purposes of this Agreement, “Cause” means the Executive’s: (i) willful misconduct,
gross negligence, fraud, embezzlement or other material dishonesty with respect to the affairs of the Company or any of its
affiliates; (ii) material failure to meet minimum performance expectations of the Board; (iii) conviction, plea of nolo contendere,
guilty plea, or confession to either a felony or any lesser crime relating to the affairs of the Company or any of its affiliates
or of which fraud, embezzlement, or moral turpitude is a material element; or (iv) a material breach of this Agreement or
a breach of a fiduciary duty owed to the Company, provided that any such breach, if curable, shall not constitute Cause unless
the Company has provided the Executive with (x) written notice of the acts or omissions giving rise to a termination of his employment
for Cause; (y) the opportunity to correct the act or omission within 30 days after receiving the Company’s notice (the “Cure
Period”); and (z) an opportunity to be heard before the Board with the Executive’s counsel present prior to the
expiration of the Cure Period. 

(d)              
Termination by the Company without Cause. The Company may not terminate the Executive’s
employment during any Term or Renewal Term without Cause. 

(e)              
Termination by the Executive. The Executive may terminate his employment at any time
for any reason other than a Good Reason, upon 30 days prior written notice. 

(f)               
Termination by the Executive for Good Reason. The Executive may terminate his employment
for Good Reason by providing written notice. For purposes of this Agreement, “Good Reason” means: (i) a material
reduction in the Executive’s Base Salary; (ii) a material diminution in the Executive’s responsibilities as CFO; (iii)
the assignment of duties to the Executive materially inconsistent with his position as CFO; (iv) the requirement that the Executive
relocate his primary place of employment more than 20 miles from Executive’s Office (unless such location is closer to the
Executive’s primary residence); or (v) the Company’s material breach of this Agreement; provided that Good Reason based
on a material breach shall exist only if within 90 days of the Company’s act or omission resulting in a material breach,
the Executive notifies the Company in a writing of the act or omission, the Company fails to correct the act or omission within
30 days after receiving the Executive’s written notice and the Executive actually terminates his employment within the 30
days following the end of such 30-day cure period.

(g)              
Expiration. Executive’s employment shall terminate on the Expiration Date.

(h)              
Termination Date. The “Termination Date” means: (i) if the Executive’s
employment is terminated by his death under Section 4(a), the date of his death; (ii) if the Executive’s employment is terminated
on account of his Disability under Section 4(b), the date on which the Company provides the Executive a written termination notice;
(iii) if the Company terminates the Executive’s employment for Cause under Section 4(c), the date on which the Company provides
the Executive a written termination notice, unless the circumstances giving rise to the termination are subject to the Cure Period,
in which case the date on which the Company provides the Executive a written termination notice following the end of the Cure
Period; (iv) if, despite the restriction against doing so under Section 4(d), the Company terminates the Executive’s employment
without Cause under Section 4(d), 90 days after the date on which the Company provides the Executive a written termination notice;
(v) if the Executive resigns his employment without Good Reason under Section 4(e), 30 days after the date on which the Executive
provides the Company a written termination notice; (vii) if the Executive resigns his employment with Good Reason under Section
4(f), the date on which the Executive provides the Company a timely written termination notice, except the Termination Date shall
be the last day of the relevant 30-day cure period, if applicable; and (viii) the Expiration Date if the Executive’s employment
terminates under Section 4(g).

    	 	4	 

     

    

5.                 
Compensation upon Termination.

(a)              
Termination by the Company for Cause; by the Executive without Good Reason; or upon the
Expiration Date following the Executive’s election not to Renew. If the Executive’s employment with the Company
is terminated pursuant to Section 4(c), 4(e), or 4(g), the Company shall pay or provide to the Executive the following amounts
through the applicable Termination Date: any earned but unpaid Base Salary, unpaid expense reimbursements, any earned but unpaid
Annual Bonus, and the value of any accrued and unused vacation days (the “Accrued Obligations”) on or before
the time required by law but in no event more than 30 days after the Executive’s Termination Date.

(b)              
Death; Disability. If the Executive’s employment terminates because of his death
as provided in Section 4(a) or because of a Disability as provided in Section 4(b), then the Executive (or his authorized representative
or estate) shall be entitled to the following: 

(i)                
the Accrued Obligations earned through the applicable Termination Date (payable on or before
the time required by law but in no event more than 30 days after the applicable Termination Date);

(ii)             
a pro-rata portion of the Executive’s Annual Bonus, if any, for the fiscal year in which
the Executive’s termination occurs (determined by multiplying the amount of such bonus which would be due for the full fiscal
year by a fraction, the numerator of which is the number of days during the fiscal year of termination that the Executive is employed
by the Company and the denominator of which is 365) payable at the same time bonuses for such year are paid to other senior executives
of the Company;

(iii)           
vest the Executive on the applicable Termination Date for any and all previously granted outstanding
equity-incentive awards subject to time-based vesting criteria as if the Executive continued to provide services to the Company
for twelve (12) months following the applicable Termination Date;

(iv)            
subject to the Executive’s or, in the event of his death, his eligible dependents’
timely election of continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”),
the Company shall reimburse the Executive or his eligible dependents the monthly premium payable to continue his and his eligible
dependents’ participation in the Company’s group health plan (to the extent permitted under applicable law and the
terms of such plan) which covers the Executive (and the Executive’s eligible dependents) for a period of eighteen (18) months,
provided that the Executive is eligible and remains eligible for COBRA coverage; and provided, further, that
in the event that the Executive obtains other employment that offers group health benefits, such continuation of coverage by the
Company shall immediately cease.  If the reimbursement of any COBRA premiums would violate the nondiscrimination rules or
cause the reimbursement of claims to be taxable under the Patient Protection and Affordable Care Act of 2010, together with the
Health Care and Education Reconciliation Act of 2010 (collectively, the “Act”) or Section 105(h) of the Internal
Revenue Code (the “Code”), the Company paid premiums shall be treated as taxable payments and be subject to imputed
income tax treatment to the extent necessary to eliminate any discriminatory treatment or taxation under the Act or Section 105(h)
of the Code; and

    	 	5	 

     

    

(v)              
in the case of a termination due to Disability, in addition to the aforementioned awards,
continuation of the Base Salary in effect on the Termination Date until the earlier of (A) the twelve month anniversary of the
Termination Date, and (B) the date Executive is eligible to commence receiving payments under the Company’s long-term disability
policy. If the net compensation from the Base Salary is greater than the net compensation from the long-term disability policy,
the Company, through the twelve month anniversary of the Termination Date will compensate the Executive’s estate the difference
in net compensation.

(c)              
Termination by the Company without Cause, by the Executive with Good Reason. If the
Executive’s employment is terminated by the Company without Cause despite the restriction against doing so under Section
4(d), or the Executive terminates his employment for Good Reason as provided in Section 4(f), then the Executive shall, except
to the extent Section 5(d) is applicable, be entitled to the following:

(i)                
the Accrued Obligations earned through the applicable Termination Date (payable on or before
the time required by law but in no event more than 30 days after the applicable Termination);

(ii)             
severance in a single lump sum installment in an amount equal to 2x the sum of (A) the Base
Salary at the rate in effect on the Termination Date , plus (B) an amount equal to 2x the maximum Annual Bonus for which the Executive
is eligible in the fiscal year in which the Termination Date occurs, or if, there is no Annual Bonus for which he is eligible in
the fiscal year in which the Termination Date occurs, 2x the Annual Bonus most recently issued to the Executive. The severance
is payable no later than thirty (30) days following the applicable Termination Date;

(iii)           
a pro-rata portion of the Executive’s Annual Bonus, if any, for the fiscal year in which
the Executive’s termination occurs (determined by multiplying the amount of such bonus which would be due for the full fiscal
year by a fraction, the numerator of which is the number of days during the fiscal year of termination that the Executive is employed
by the Company and the denominator of which is 365) payable at the same time bonuses for such year are paid to other senior executives
of the Company;

(iv)            
full vesting of the Executive in any and all previously granted outstanding equity-based incentive
awards subject to time-based vesting criteria; and

(v)              
subject to the Executive’s timely election of continuation coverage under COBRA, the
Company shall reimburse the Executive the monthly premium payable to continue his and his eligible dependents’ participation
in the Company’s group health plan (to the extent permitted under applicable law and the terms of such plan) which covers
the Executive (and the Executive’s eligible dependents) for a period of eighteen (18) months, provided that the Executive
is eligible and remains eligible for COBRA coverage; and provided, further, that in the event that the Executive
obtains other employment that offers group health benefits, such continuation of coverage by the Company shall immediately cease.
 If the reimbursement of any COBRA premiums would violate the nondiscrimination rules or cause the reimbursement of claims
to be taxable under the Act or Section 105(h) of the Code, the Company paid premiums shall be treated as taxable payments and
be subject to imputed income tax treatment to the extent necessary to eliminate any discriminatory treatment or taxation under
the Act or Section 105(h) of the Code.

    	 	6	 

     

    

(d)              
Change of Control: Termination by the Company without Cause, by the Executive with Good
Reason. If the Executive’s employment is terminated by the Company in breach of Section 4(d), or the Executive terminates
his employment for Good Reason as provided in Section 4(f), and such termination occurs (x) at the same time as, or within
the twelve (12) month period following, the consummation of a Change in Control or (y) within the sixty (60) day
period prior to the date of a Change in Control where the Change in Control was under consideration at the time of Executive’s
Termination Date, then the Executive shall be entitled to the following:

(i)                
the Accrued Obligations earned through the Termination Date (payable on or before the time
required by law but in no event more than 30 days after the applicable Termination).

(ii)             
severance in a single lump sum installment in amount equal to 2x the sum of (A) the Base Salary
at the rate in effect on the Termination Date, plus (B) an amount equal to 2x the maximum Annual Bonus for which the Executive
is eligible in the fiscal year in which the Termination Date occurs, or, if, there is no Annual Bonus for which he is eligible
in the fiscal year of the Termination Date, 2x the Annual Bonus most recently issued to the Executive. If either the Base Salary
or Annual Bonus has been reduced either 60 days prior to a Change in Control or within twelve (12) months following a Change in
Control then severance shall be based upon the previously highest Base Salary and the highest Annual Bonus previously awarded to
the Executive. The severance is payable no later than thirty (30) days following the Termination Date.

(iii)           
A pro-rata portion of the Executive’s Annual Bonus, if any, for the fiscal year in which
the Executive’s termination occurs (determined by multiplying the amount of such bonus which would be due for the full fiscal
year by a fraction, the numerator of which is the number of days during the fiscal year of termination that the Executive is employed
by the Company and the denominator of which is 365) payable at the same time bonuses for such year are paid to other senior executives
of the Company. If there is no Annual Bonus for which he is eligible in the fiscal year of the Termination Date, then the award
shall be based upon a pro rata share of the Annual Bonus most recently issued to the Executive. If the Annual Bonus has been reduced
either 60 days prior to a Change in Control or within twelve (12) months following a Change in Control then such pro-rata bonus
shall be based upon the highest Annual Bonus previously awarded to the Executive. 

(iv)            
full vesting of the Executive in any and all outstanding previously granted equity-based incentive
awards subject to time-based vesting criteria.

(v)              
subject to the Executive’s timely election of continuation coverage under COBRA, reimbursement
by the Company of the monthly premium payable to continue the Executive’s and his eligible dependents’ participation
in the Company’s group health plan (to the extent permitted under applicable law and the terms of such plan) which covers
the Executive (and the Executive’s eligible dependents) for a period of eighteen (18) months, provided that the Executive
is eligible and remains eligible for COBRA coverage; and provided, further, that in the event that the Executive
obtains other employment that offers group health benefits, such continuation of coverage by the Company shall immediately cease.
 If the reimbursement of any COBRA premiums would violate the nondiscrimination rules or cause the reimbursement of claims
to be taxable under the Act or Section 105(h) of the Code, the Company paid premiums shall be treated as taxable payments and
be subject to imputed income tax treatment to the extent necessary to eliminate any discriminatory treatment or taxation under
the Act or Section 105(h) of the Code.

    	 	7	 

     

    

 

(e)              
Change of Control: For purposes of Section 5(d), a change of control shall have occurred
upon any of the following:

(i)                
any person or entity or group becoming the beneficial owner, directly or indirectly, of securities
of the Company representing more than fifty (50%) percent of the total voting power of all its then outstanding voting securities;

(ii)             
a merger or consolidation of the Company in which its voting securities immediately prior
to the merger or consolidation do not represent, or are not converted into securities that represent, a majority of the voting
power of all voting securities of the surviving entity immediately after the merger or consolidation; 

(iii)           
a sale of substantially all of the assets of the Company or a liquidation or dissolution of
the Company; or 

(iv)            
individuals who, as of the date of the signing of this Agreement, constitute the Board of
Directors (the “Incumbent Board”) cease for any reason to constitute at least a majority of such Board; provided that
any individual who becomes a director of the Company subsequent to the date of the signing of this Agreement, whose election, or
nomination for election by the Company stockholders, was approved by the vote of at least a majority of the directors then in office
shall be deemed a member of the Incumbent Board. 

(f)               
 Consequence of a Change in Control. Notwithstanding the terms of any employee compensation
plan, if, as of the date of a Change in Control, Executive holds equity awards issued under such a plan that are not vested and,
if applicable, exercisable, such equity awards shall become fully vested and, if applicable, exercisable as of the date of the
Change in Control if the acquirer does not agree to assume or substitute for equivalent equity awards such outstanding unvested
equity awards. 

(g)              
No Mitigation or Offset. In the event of any termination of Executive’s employment
hereunder, Executive shall be under no obligation to seek other employment or otherwise mitigate the obligations of the Company
under this Agreement, and there shall be no offset against any amounts due under this Agreement on account of any remuneration
attributable to any subsequent employment that Executive may obtain.

(h)              
Effect of Termination on Officer and Board Positions. Any termination of the Executive
with respect to the Executive’s standing as an executive officer or Board Member must expressly designate which such role
is subject to termination. The termination of the Executive as an Officer will not thereby terminate the Executive’s Board
status unless the termination so states, in which event the Executive shall resign his Board position as a condition to receiving
any of the payments set forth in this Section 5.

6.                 
Section 409A Compliance.

(a)              
All in-kind benefits provided and expenses eligible for reimbursement under this Agreement
shall be provided by the Company or incurred by the Executive during the time periods set forth in this Agreement. All reimbursements
shall be paid as soon as administratively practicable, but in no event shall any reimbursement be paid after the last day of the
taxable year following the taxable year in which the expense was incurred. The amount of in-kind benefits provided or reimbursable
expenses incurred in one taxable year shall not affect the in-kind benefits to be provided or the expenses eligible for reimbursement
in any other taxable year. Such right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another
benefit.

    	 	8	 

     

    

(b)              
To the extent that any of the payments or benefits provided for in Section 5(b), (c) or (d)
are deemed to constitute non-qualified deferred compensation benefits subject to Section 409A of the United States Internal Revenue
Code (the “Code”), the following interpretations apply to Section 5: 

(i)                
Any termination of the Executive’s employment triggering payment of benefits under Section
5(b), (c) or (d) must constitute a “separation from service” under Section 409A(a)(2)(A)(i) of the Code and Treas.
Reg. §1.409A-1(h) before distribution of such benefits can commence. To the extent that the termination of the Executive’s
employment does not constitute a separation of service under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h)
(as the result of further services that are reasonably anticipated to be provided by the Executive to the Company or any of its
parents, subsidiaries or affiliates at the time the Executive’s employment terminates), any benefits payable under Section
5(b), (c) or (d) that constitute deferred compensation under Section 409A of the Code shall be delayed until after the date of
a subsequent event constituting a separation of service under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h).
For purposes of clarification, this Section 6(b)(i) shall not cause any forfeiture of benefits on the Executive’s part, but
shall only act as a delay until such time as a “separation from service” occurs.

(ii)             
If the Executive is a “specified employee” (as that term is used in Section 409A
of the Code and regulations and other guidance issued thereunder) on the date his separation from service becomes effective, any
benefits payable under Section 5(b), (c) or (d) that constitute non-qualified deferred compensation under Section 409A of the Code
shall be delayed until the earlier of (A) the business day following the six-month anniversary of the date his separation from
service becomes effective, and (B) the date of the Executive’s death, but only to the extent necessary to avoid such penalties
under Section 409A of the Code. On the earlier of (A) the business day following the six-month anniversary of the date his separation
from service becomes effective, and (B) the Executive’s death, the Company shall pay the Executive in a lump sum the aggregate
value of the non-qualified deferred compensation that the Company otherwise would have paid the Executive prior to that date under
Section 5(b), (c) or (d) of this Agreement.

(iii)           
It is intended that each installment of the payments and benefits provided under Section 5(b),
(c) or (d) of this Agreement shall be treated as a separate “payment” for purposes of Section 409A of the Code. 

(iv)            
Neither the Company nor the Executive shall have the right to accelerate or defer the delivery
of any such payments or benefits except to the extent specifically permitted or required by Section 409A of the Code.

7.                 
Excess Parachute Payments.

(a)              
To the extent that any payment, benefit or distribution of any type to or for the benefit
of the Executive by the Company or any of its affiliates, whether paid or payable, provided or to be provided, or distributed
or distributable pursuant to the terms of this Agreement or otherwise (including, without limitation, any accelerated vesting
of stock options or other equity-based awards) (collectively, the “Total Payments”) would be subject to the
excise tax imposed under Section 4999 of the Internal Revenue Code of 1986, as amended (the “Code”), then the
Total Payments shall be reduced (but not below zero) so that the maximum amount of the Total Payments (after reduction) shall
be one dollar ($1.00) less than the amount which would cause the Total Payments to be subject to the excise tax imposed by Section
4999 of the Code, but only if the Total Payments so reduced result in the Executive receiving a net after tax amount that exceeds
the net after tax amount the Executive would receive if the Total Payments were not reduced and were instead subject to the excise
tax imposed on excess parachute payments by Section 4999 of the Code. Unless the Executive shall have given prior written notice
to the Company to effectuate a reduction in the Total Payments if such a reduction is required, any such notice consistent with
the requirements of Section 409A of the Code to avoid the imputation of any tax, penalty or interest thereunder, the Company shall
reduce or eliminate the Total Payments by first reducing or eliminating any cash severance benefits (with the payments to be made
furthest in the future being reduced first), then by reducing or eliminating any accelerated vesting of stock options or similar
awards, then by reducing or eliminating any accelerated vesting of restricted stock or similar awards, then by reducing or eliminating
any other remaining Total Payments. The preceding provisions of this Section 7(a) shall take precedence over the provisions of
any other plan, arrangement or agreement governing the Executive’s rights and entitlements to any benefits or compensation.

    	 	9	 

     

    

(b)              
If the Total Payments to the Executive are reduced in accordance with Section 7(a), as a result
of the uncertainty in the application of Section 4999 of the Code at the time of the initial reduction under Section 7(a), it is
possible that Total Payments to the Executive which will not have been made by the Company should have been made (“Underpayment”)
or that Total Payments to the Executive which were made should not have been made (“Overpayment”). If an Underpayment
has occurred, the amount of any such Underpayment shall be promptly paid by the Company to or for the benefit of the Executive.
In the event of an Overpayment, then the Executive shall promptly repay to the Company the amount of any such Overpayment together
with interest on such amount (at the same rate as is applied to determine the present value of payments under Section 280G of the
Code or any successor thereto), from the date the reimbursable payment was received by the Executive to the date the same is repaid
to the Company

8.                 
Confidentiality and Restrictive Covenants. 

(a)                     
Covenant Against Disclosure. All Confidential Information (defined below) relating to the Business of the Company
and its affiliates is, shall be and shall remain the sole property and confidential business information of them, free of any rights
of the Executive. The Executive shall not make any use of the Confidential Information except in the performance of his duties
hereunder and shall not disclose any Confidential Information or trade secret to third parties except as required by law, with
the limited qualification that in accordance with the Defend Trade Secrets Act of 2016, an individual shall not be held criminally
or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that is made either: (1) in
confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney, solely for the
purpose of reporting or investigating a suspected violation of law; or (2) in a complaint or other document filed in a lawsuit
or other proceeding, if such filing is made under seal, “Confidential Information” includes without limitation such
documents as business plans, source code, documentation, financial analysis, marketing plans, customer names, customer lists, customer
data, contracts and other business information, including the information of the Company and its affiliates, existing or prospective
customers, clients, investors or other third parties with whom the Company and its affiliates hereto have relationships or conduct
business that may be disclosed to the Executive as part of the Executive’s employment. Notwithstanding anything else set
forth herein, nothing in this Agreement shall be construed to prohibit the Executive from reporting, without first notifying the
Company or otherwise, possible violations of law or regulation to any governmental agency or entity.

(b)         
Return of Company Documents. On the Termination Date or on any prior date upon the Company’s written demand,
the Executive will return all Confidential Information in his possession, directly or indirectly, that is in written or other
tangible form (together with all duplicates thereof).

    	 	10	 

     

    

(c)         
Further Covenant. During the Term and through the first anniversary of the Termination Date, the Executive shall
not, directly or indirectly, take any of the following actions, and, to the extent the Executive owns, manages, operates, controls,
is employed by or participates in the ownership, management, operation or control of, or is connected in any manner with, any business,
the Executive will use his best efforts to ensure that such business does not take any of the following actions:

(i)                
persuade or attempt to persuade any customer of the Company or its affiliates to cease doing business with the Company or
its affiliates, or to reduce the amount of business any customer does with the Company or its affiliates;

(ii)              
solicit for himself or any entity the business of a person or entity that was a customer of the Company or its affiliates
within the twelve (12) months prior to the termination of the Executive’s employment, in competition with the Company or
its affiliates; or

(iii)            
persuade or attempt to persuade any employee of the Company or its affiliates to leave the employ of the Company or its
affiliates, or hire or engage, directly or indirectly, any individual who was an employee of the Company or its affiliates within
one (1) year prior to the Executive’s Termination Date.

9.                 
D&O Insurance.  At the request of the Executive, the Company obtain and continue
for as long as Executive is employed by the Company, directors’ and officers’ insurance coverage at levels no less
than $5,000,000 with an insurance company rated “A” or higher.

10.             
Waiver. Except with respect to opportunities in which the Company would be interested
in the ordinary course of its business and which are presented to the Executive in his capacity as a director or executive officer
of the Company, the Board has renounced on behalf of the Company and its shareholders all interest and expectancy to (or being
offered any opportunity to participate in) any opportunity presented to the Executive that may be considered a corporate opportunity
of the Company, and the Executive shall have no obligation to communicate, offer, or present any opportunity presented to the Executive
that may be considered a corporate opportunity of the Company, whether centered on geography, land rights, or otherwise (the “Renouncement”). 
The Company acknowledges that the Renouncement is a material term of this Agreement and the Executive is specifically relying on
the Renouncement in agreeing to enter into this Agreement.  Except with respect to opportunities in which the Company would
be interested in the ordinary course of its business and which are presented to the Executive in his capacity as a director or
executive officer of the Company, to the fullest extent permitted by law, the Company hereby prospectively waives any and all claims
arising from any business transacted by the Executive that could be construed as a corporate opportunity of the Company. 
A copy of the Board resolution is attached hereto as Exhibit B.

11.             
No Disparagement. During the Term and through the second anniversary of the Termination
Date, the Executive will not make public statements or communications that disparage the Company or any of its businesses, services,
products, affiliates or current, former or future directors and executive officers in their capacity as such. During the Term and
through the second anniversary of the Termination Date, the Company will instruct its directors and executives not to make public
statements or communications that disparage the Executive. The foregoing obligations shall not be violated by truthful statements
to any governmental agency or entity, required governmental testimony or filings, or administrative or arbitral proceedings (including,
without limitation, depositions in connection with such proceedings).

    	 	11	 

     

    

 

12.             
Indemnification. During the Term and thereafter, the Company shall indemnify and hold
the Executive and the Executive’s heirs and representatives harmless, to the maximum extent permitted by law, against any
and all damages, costs, liabilities, losses and expenses (including reasonable attorneys’ fees) as a result of any claim
or proceeding (whether civil, criminal, administrative or investigative), or any threatened claim or proceeding (whether civil,
criminal, administrative or investigative), against the Executive that arises out of or relates to the Executive’s service
as an officer, director or employee, as the case may be, of the Company, or the Executive’s service in any such capacity
or similar capacity with any affiliate of the Company or other entity at the Company’s request, both prior to and after the
Effective Date, and to promptly advance to the Executive or the Executive’s heirs or representatives such expenses, including
litigation costs and attorneys’ fees, upon written request with appropriate documentation of such expense upon receipt of
an undertaking by the Executive or on the Executive’s behalf to repay such amount if it shall ultimately be determined that
the Executive is not entitled to be indemnified by the Company. During the Term and thereafter, the Company also shall provide
the Executive with coverage under its then current directors’ and officers’ liability policy to the same extent that
it provides such coverage to its other executive officers. If the Executive has any knowledge of any actual or threatened action,
suit or proceeding, whether civil, criminal, administrative or investigative, as to which the Executive may request indemnity under
this provision, the Executive will give the Company prompt written notice thereof; provided that the failure to give such notice
shall not affect the Executive’s right to indemnification. The Company shall be entitled to assume the defense of any such
proceeding and the Executive will use reasonable efforts to cooperate with such defense. To the extent that the Executive in good
faith determines that there is an actual or potential conflict of interest between the Company and the Executive in connection
with the defense of a proceeding, the Executive shall so notify the Company and shall be entitled to separate representation at
the Company’s expense by counsel selected by the Executive (provided that the Company may reasonably object to the selection
of counsel within ten (10) business days after notification thereof) which counsel shall cooperate, and coordinate the defense,
with the Company’s counsel and minimize the expense of such separate representation to the extent consistent with the Executive’s
separate defense. This Section 12 shall continue in effect after the termination of the Executive’s employment or the termination
of this Agreement

13.             
Disputes.

(a)              
Any dispute or controversy arising out of or relating to this Agreement or your employment
shall be brought solely in the state and federal courts located in the State and County of New York.

(b)              
BOTH THE COMPANY AND THE EXECUTIVE HEREBY WAIVE ANY RIGHT TO A TRIAL BY JURY TO THE MAXIMUM
EXTENT PERMITTED BY APPLICABLE FEDERAL OR STATE LAW.

(c)              
In the event of any contest or dispute relating to this Agreement or the termination of Executive’s
employment hereunder, the non-prevailing party in any such contest or dispute shall be liable for the attorneys’ fees and
costs of the prevailing party.

14.             
Integration. This Agreement constitutes the entire agreement between the parties with
respect to the subject matter hereof and supersedes all prior agreements between the parties concerning such subject matter.

15.             
Successors. This Agreement shall inure to the benefit of and be enforceable by the
Executive’s personal representatives, executors, administrators, heirs, distributees, devisees and legatees. In the event
of the Executive’s death after his termination of employment but prior to the completion by the Company of all payments due
him under this Agreement, the Company shall continue such payments to the Executive’s beneficiary designated in writing to
the Company prior to his death (or to his estate, if the Executive fails to make such designation). The Company shall require any
successor to the Company to expressly assume and agree to perform this Agreement in the same manner and to the same extent that
the Company would be required to perform it if no such succession had taken place.

16.             
Enforceability. If any portion or provision of this Agreement (including, without
limitation, any portion or provision of any section of this Agreement) shall to any extent be declared illegal or unenforceable
by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in
circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each
portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.

    	 	12	 

     

    

17.             Survival.
The provisions of this Agreement shall survive the termination of this Agreement or the termination of the Executive’s employment
to the extent necessary to effectuate the terms contained herein.

18.             Waiver.
No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure of any
party to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach of this
Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.

19.             Notices.
Any notices, requests, demands and other communications provided for by this Agreement shall be sufficient if in writing and delivered
in person or sent by a nationally recognized overnight courier service or by registered or certified mail, postage prepaid, return
receipt requested, to the Executive at the last address the Executive has filed in writing with the Company or, in the case of
the Company, at its main offices,

	 	If to Executive:	Stuart Benson
	 	 	4 Earl Court
	 	 	Montville, NJ 07045
	 	 	 
	 	If to Company:	Helios and Matheson Analytics
Inc.
	 	 	350 Fifth Avenue
	 	 	New York, NY 10118
	 	 	Attention: Chief Executive Officer
	 	 	 

 20.            Amendment. This Agreement may be amended or modified only by a written instrument signed by the Executive and by
a duly authorized representative of the Company.

21.             Governing
Law. This is a New York contract and shall be construed under and be governed in all respects by the laws of New York for
contracts to be performed in that State and without giving effect to the conflict of laws principles of New York or any other
State.

22.             Counterparts. This Agreement may be executed in any number of counterparts, each of
which when so executed and delivered shall be taken to be an original; but such counterparts shall together constitute one and
the same document.

    	 	13	 

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Agreement effective on the date and year first above written.

 

	 	HELIOS AND MATHESON ANALYTICS
    INC.
	 	 
	 	By: 	/s/ Theodore Farnsworth
	 	 	Name:
    Theodore Farnsworth
Title:
    Chief Executive Officer
	 	 	 
	 	 	 
	 	 	 
	 	STUART BENSON
	 	 
	 	 
	 	 	/s/
    Stuart Benson

 

    	 	14	 

     

    

 

Exhibit A

 

Initial Award

 

As of the Effective
Date, the Company shall grant to the Executive 600,000 shares of common stock (subject to proportionate adjustment for any stock
split or combination or other recapitalization event), subject to the terms of the applicable Award Agreement. The shares shall
vest in their entirety on February 15, 2019, which is eighteen (18) months following August 15, 2017, the date on which the Company
entered into a Securities Purchase Agreement to acquire a majority stake in MoviePass Inc. (the “MoviePass SPA”),
which contemplated that the Company would enter into an employment agreement with the Executive prior to the closing under the
MoviePass SPA.

 

Treatment
resulting from termination of employment

 

	Death
    or Disability	All
    unvested award shares immediately vest on the applicable Termination Date.
	Voluntary
    quit	All
    awards that did not yet vest will be cancelled on the last day of employment.
	Termination
    for Cause	All
    awards that did not yet vest will be cancelled on the last day of employment.
	Termination
    without Cause/ Quit for Good Reason	All
    unvested award shares immediately vest on the applicable Termination Date.

 

 

The
terms of any award under this Exhibit shall be more fully set forth in an Award Agreement. It is expressly acknowledged and agreed
that this Exhibit B is a summary of the contemplated terms of the applicable Award Agreement, which shall be subject to the Company’s
receipt of all corporate approvals required by applicable law or the rules and regulations of the Principal Market prior to effectiveness
thereof. To the extent that there is any conflict between the terms of this Exhibit B and the applicable Award Agreement, the
terms of the Award Agreement shall govern.

 

    	 	15	 

     

    

 

Exhibit
B

 

(Board
Resolutions for Prospective Waiver of Corporate Opportunities)

 

    	 	16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}]]